High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements

general

High-grade B-cell lymphoma characterized by the abnormal rearrangement of MYC gene, BCL2 gene, and BCL6 gene. Patients with this type of lymphoma usually respond poorly to standard treatments and have a poor prognosis.

Centers

Active Trials

—

Cancer Funding

Specific Cancer Types(1)

Name	Centers	Active Trials
High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements	30	1

Top Centers for High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements(40)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Research Tier	Active Trials	Cancer Funding	Score
1	Siteman Cancer CenterSt. Louis, MO NCI Comprehensive High-Volume Research Center	High-Volume Research Center	2	—	70.4
2	The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL NCI Comprehensive High-Volume Research Center	High-Volume Research Center	2	—	70.4
3	The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive High-Volume Research Center	High-Volume Research Center	2	—	70.4
4	University of Illinois Cancer CenterChicago, IL High-Volume Research Center	High-Volume Research Center	2	—	70.4
5	Cancer Center at IllinoisUrbana, IL High-Volume Research Center	High-Volume Research Center	2	—	70.4
6	Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL High-Volume Research Center	High-Volume Research Center	3	—	70.4
7	Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program	Active Research Program	1	—	56.3
8	Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive Active Research Program	Active Research Program	1	—	56.3
9	Dan L Duncan Comprehensive Cancer Center at Baylor College of MedicineHouston, TX NCI Comprehensive Active Research Program	Active Research Program	1	—	56.3
10	Simmons Comprehensive Cancer Center UT Southwestern Medical CenterDallas, TX NCI Comprehensive Active Research Program	Active Research Program	1	—	56.3
11	Laura and Isaac Perlmutter Cancer Center at NYU Langone HealthNew York, NY NCI Comprehensive Active Research Program	Active Research Program	1	—	56.3
12	The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program	Active Research Program	1	—	56.3
13	City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program	Active Research Program	1	—	56.3
14	Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program	Active Research Program	1	—	56.3
15	Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive Active Research Program	Active Research Program	1	—	56.3
16	Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program	Active Research Program	1	—	56.3
17	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program	Active Research Program	1	—	56.3
18	UCI Chao Family Comprehensive Cancer CenterOrange, CA NCI Comprehensive Active Research Program	Active Research Program	1	—	56.3
19	Medical College of Wisconsin Cancer CenterMilwaukee, WI Active Research Program	Active Research Program	1	—	56.3
20	Cedars-Sinai CancerLos Angeles, CA Active Research Program	Active Research Program	1	—	56.3
21	VCU Massey Comprehensive Cancer CenterRichmond, VA NCI Comprehensive Active Research Program	Active Research Program	1	—	56.3
22	Wilmot Cancer Institute, UR MedicineRochester, NY NCI Clinical Active Research Program	Active Research Program	1	—	56.3
23	The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program	Active Research Program	1	—	56.3
24	Dartmouth Cancer CenterLebanon, NH NCI Comprehensive Active Research Program	Active Research Program	1	—	56.3
25	Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ Active Research Program	Active Research Program	1	—	56.3
26	Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive		—	—	37.2
27	Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive		—	—	37.2
28	UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive		—	—	37.2
29	Winship Cancer InstituteAtlanta, GA NCI Comprehensive		—	—	37.2
30	University of Colorado Cancer CenterAurora, CO NCI Comprehensive		—	—	37.2
31	Sylvester Comprehensive Cancer CenterMiami, FL NCI Clinical		—	—	37.2
32	Cleveland Clinic Cancer CenterCleveland, OH		—	—	37.2
33	Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical		—	—	37.2
34	Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive		—	—	37.2
35	University of Hawai‘i Cancer CenterHonolulu, HI NCI Clinical		—	—	37.2
36	UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR		—	—	37.2
37	Boston University Cancer CenterBoston, MA		—	—	37.2
38	Georgia Cancer Center, Augusta UniversityAugusta, GA		—	—	37.2
39	Upstate Cancer CenterSyracuse, NY		—	—	37.2
40	Louisiana Cancer Research CenterNew Orleans, LA		—	—	37.2

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →